Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Metadata
Title
Retraction Note: EANM Abstracts 2013
Author
John Smith
Publication date
01-05-2014
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 5/2014
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-013-2661-y

Other articles of this Issue 5/2014

European Journal of Nuclear Medicine and Molecular Imaging 5/2014 Go to the issue

Original Article

Impact of initial PET/CT staging in terms of clinical stage, management plan, and prognosis in 592 patients with non-small-cell lung cancer

Original Article

Arterial and fat tissue inflammation are highly correlated : a prospective 18F-FDG PET/CT study

Original Article

Anatomical and functional volume concordance between FDG PET, and T2 and diffusion-weighted MRI for cervical cancer: a hybrid PET/MR study

Image of the Month

FDG gated cardiac PET at rest and immediately after dobutamine stress

Editorial Commentary

Evolving role of PET/CT with different tracers in the evaluation of pulmonary neuroendocrine tumours

Original Article

Altered serotonin transporter availability in patients with multiple sclerosis